Source: https://www.law.cornell.edu/cfr/text/21/part-14/subpart-C
Timestamp: 2017-05-28 01:38:03
Document Index: 92435139

Matched Legal Cases: ['art 14', 'art 14', 'art 14', '§ 14', '§ 14', '§ 41', '§\u202f2', '§ 50', '§ 141', '§ 142', '§ 143', '§ 144', '§ 145', '§ 146', '§ 147', '§ 148', '§ 149', '§ 321', '§ 321', '§ 321', '§ 321', '§ 321', '§ 331', '§ 332', '§ 333', '§ 333', '§\u202f1905', '§ 334', '§ 335', '§ 335', '§ 335', '§ 335', '§ 336', '§ 337', '§ 341', '§ 342', '§ 343', '§ 343', '§ 343', '§ 343', '§ 343', '§\u202f1', '§\u202f517', '§ 344', '§ 345', '§ 346', '§ 346', '§ 346', '§ 347', '§ 347', '§ 347', '§ 348', '§ 349', '§ 350', '§ 350', '§ 350', '§ 350', '§ 350', '§ 350', '§ 350', '§ 350', '§ 350', '§ 350', '§ 350', '§ 350', '§ 350', '§ 350', '§ 351', '§ 352', '§ 353', '§ 353', '§ 353', '§ 354', '§ 355', '§ 355', '§ 355', '§ 355', '§ 355', '§ 355', '§ 355', '§ 356', '§ 356', '§ 356', '§ 356', '§ 356', '§ 357', '§ 358', '§ 359', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§\u202f601', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 361', '§ 362', '§ 363', '§ 364', '§\u202f103', '§ 371', '§ 372', '§ 372', '§ 373', '§ 374', '§ 374', '§ 375', '§ 376', '§ 377', '§ 378', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 379', '§ 381', '§ 382', '§ 383', '§ 384', '§ 384', '§ 384', '§ 384', '§ 384', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 387', '§ 391', '§ 392', '§ 393', '§ 393', '§ 394', '§ 467', '§ 679', '§ 821', '§ 1034', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14']

21 CFR Part 14, Subpart C - Establishment of Advisory Committees | US Law | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter A › Part 14 › Subpart C 21 CFR Part 14, Subpart C - Establishment of Advisory Committees
§ 14.40 Establishment and renewal of advisory committees.
§ 14.55 Termination of advisory committees.
U.S. Code: Title 21 - FOOD AND DRUGS§ 41 to 50 - Repealed. Pub. L. 104–128, § 2, Apr. 9, 1996, 110 Stat. 1198§ 50§ 141 - Prohibition of importation without permit§ 142 - Milk or cream when unfit for importation§ 143 - Inspection; certified statement in lieu thereof; waiver of requirements of section 142; regulations; suspension and revocation of permits§ 144 - Unlawful receiving of imported milk or cream§ 145 - Penalties§ 146 - Authorization of appropriations§ 147 - Repeal of inconsistent laws§ 148 - Powers of State with respect to milk or cream lawfully imported§ 149 - Definitions§ 321 - Definitions; generally§ 321a - “Butter” defined§ 321b - “Package” defined§ 321c - Nonfat dry milk; “milk” defined§ 321d - Market names for catfish and ginseng§ 331 - Prohibited acts§ 332 - Injunction proceedings§ 333 - Penalties§ 333a - Repealed. Pub. L. 101–647, title XIX, § 1905, Nov. 29, 1990, 104 Stat. 4853§ 334 - Seizure§ 335 - Hearing before report of criminal violation§ 335a - Debarment, temporary denial of approval, and suspension§ 335b - Civil penalties§ 335c - Authority to withdraw approval of abbreviated drug applications§ 336 - Report of minor violations§ 337 - Proceedings in name of United States; provision as to subpoenas§ 341 - Definitions and standards for food§ 342 - Adulterated food§ 343 - Misbranded food§ 343-1§ 343-2§ 343-3§ 343a - Repealed. Pub. L. 106–554, § 1(a)(1) [title V, § 517], Dec. 21, 2000, 114 Stat. 2763, 2763A–73§ 344 - Emergency permit control§ 345 - Regulations making exemptions§ 346 - Tolerances for poisonous or deleterious substances in food; regulations§ 346a - Tolerances and exemptions for pesticide chemical residues§ 346b - Authorization of appropriations§ 347 - Intrastate sales of colored oleomargarine§ 347a - Congressional declaration of policy regarding oleomargarine sales§ 347b - Contravention of State laws§ 348 - Food additives§ 349 - Bottled drinking water standards; publication in Federal Register§ 350 - Vitamins and minerals§ 350a - Infant formulas§ 350b - New dietary ingredients§ 350c - Maintenance and inspection of records§ 350d - Registration of food facilities§ 350e - Sanitary transportation practices§ 350f - Reportable food registry§ 350g - Hazard analysis and risk-based preventive controls§ 350h - Standards for produce safety§ 350i - Protection against intentional adulteration§ 350j - Targeting of inspection resources for domestic facilities, foreign facilities, and ports of entry; annual report§ 350k - Laboratory accreditation for analyses of foods§ 350l - Mandatory recall authority§ 350l-1§ 351 - Adulterated drugs and devices§ 352 - Misbranded drugs and devices§ 353 - Exemptions and consideration for certain drugs, devices, and biological products§ 353a - Pharmacy compounding§ 353b - Outsourcing facilities§ 354 - Veterinary feed directive drugs§ 355 - New drugs§ 355-1§ 355a - Pediatric studies of drugs§ 355b - Adverse-event reporting§ 355c - Research into pediatric uses for drugs and biological products§ 355d - Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers§ 355e - Pharmaceutical security§ 356 - Expedited approval of drugs for serious or life-threatening diseases or conditions§ 356-1§ 356a - Manufacturing changes§ 356b - Reports of postmarketing studies§ 356c - Discontinuance or interruption in the production of life-saving drugs§ 357 - Qualification of drug development tools§ 358 - Authority to designate official names§ 359 - Nonapplicability of subchapter to cosmetics§ 360 - Registration of producers of drugs or devices§ 360a - Clinical trial guidance for antibiotic drugs§ 360b - New animal drugs§ 360c - Classification of devices intended for human use§ 360d - Performance standards§ 360e - Premarket approval§ 360e-1§ 360f - Banned devices§ 360g - Judicial review§ 360h - Notification and other remedies§ 360i - Records and reports on devices§ 360j - General provisions respecting control of devices intended for human use§ 360k - State and local requirements respecting devices§ 360l - Postmarket surveillance§ 360m - Accredited persons§ 360n - Priority review to encourage treatments for tropical diseases§ 360aa - Recommendations for investigations of drugs for rare diseases or conditions§ 360bb - Designation of drugs for rare diseases or conditions§ 360cc - Protection for drugs for rare diseases or conditions§ 360dd - Open protocols for investigations of drugs for rare diseases or conditions§ 360ee - Grants and contracts for development of drugs for rare diseases and conditions§ 360hh - Definitions§ 360ii - Program of control§ 360jj - Studies by Secretary§ 360kk - Performance standards for electronic products§ 360ll - Notification of defects in and repair or replacement of electronic products§ 360mm - Imports§ 360nn - Inspection, records, and reports§ 360oo - Prohibited acts§ 360pp - Enforcement§ 360qq - Repealed. Pub. L. 105–362, title VI, § 601(a)(2)(A), Nov. 10, 1998, 112 Stat. 3285§ 360rr - Federal-State cooperation§ 360ss - State standards§ 360aaa to 360aaa–6 - Omitted§ 360bbb - Expanded access to unapproved therapies and diagnostics§ 360bbb-1§ 360bbb-2§ 360bbb-3§ 360bbb-4§ 360bbb-5§ 360bbb-6§ 360ccc - Conditional approval of new animal drugs for minor use and minor species§ 360ccc-1§ 360ccc-2§ 361 - Adulterated cosmetics§ 362 - Misbranded cosmetics§ 363 - Regulations making exemptions§ 364 - Repealed. Pub. L. 86–618, title I, § 103(a)(3), July 12, 1960, 74 Stat. 398§ 371 - Regulations and hearings§ 372 - Examinations and investigations§ 372a - Transferred§ 373 - Records§ 374 - Inspection§ 374a - Inspections relating to food allergens§ 375 - Publicity§ 376 - Examination of sea food on request of packer; marking food with results; fees; penalties§ 377 - Revision of United States Pharmacopoeia; development of analysis and mechanical and physical tests§ 378 - Advertising of foods§ 379 - Confidential information§ 379a - Presumption of existence of jurisdiction§ 379b - Consolidated administrative and laboratory facility§ 379c - Transferred§ 379d - Automation of Food and Drug Administration§ 379d-1§ 379d-2§ 379e - Listing and certification of color additives for foods, drugs, devices, and cosmetics§ 379f - Recovery and retention of fees for freedom of information requests§ 379g - Definitions§ 379h - Authority to assess and use drug fees§ 379h-1§ 379h-2§ 379i - Definitions§ 379j - Authority to assess and use device fees§ 379j-1§ 379j-11§ 379j-12§ 379j-13§ 379j-21§ 379j-22§ 379j-31§ 379k - Information system§ 379l - Education§ 379o - Environmental impact§ 379r - National uniformity for nonprescription drugs§ 379s - Preemption for labeling or packaging of cosmetics§ 379v - Safety report disclaimers§ 379aa - Serious adverse event reporting for nonprescription drugs§ 379aa-1§ 379dd - Establishment and functions of the Foundation§ 379dd-1§ 379dd-2§ 381 - Imports and exports§ 382 - Exports of certain unapproved products§ 383 - Office of International Relations§ 384 - Importation of prescription drugs§ 384a - Foreign supplier verification program§ 384b - Voluntary qualified importer program§ 384c - Inspection of foreign food facilities§ 384d - Accreditation of third-party auditors§ 387 - Definitions§ 387a - FDA authority over tobacco products§ 387a-1§ 387b - Adulterated tobacco products§ 387c - Misbranded tobacco products§ 387d - Submission of health information to the Secretary§ 387e - Annual registration§ 387f - General provisions respecting control of tobacco products§ 387f-1§ 387g - Tobacco product standards§ 387h - Notification and other remedies§ 387i - Records and reports on tobacco products§ 387j - Application for review of certain tobacco products§ 387k - Modified risk tobacco products§ 387l - Judicial review§ 387m - Equal treatment of retail outlets§ 387n - Jurisdiction of and coordination with the Federal Trade Commission§ 387o - Regulation requirement§ 387p - Preservation of State and local authority§ 387q - Tobacco Products Scientific Advisory Committee§ 387r - Drug products used to treat tobacco dependence§ 387s - User fees§ 387t - Labeling, recordkeeping, records inspection§ 387u - Studies of progress and effectiveness§ 391 - Separability clause§ 392 - Exemption of meats and meat food products§ 393 - Food and Drug Administration§ 393a - Office of Pediatric Therapeutics§ 394 - Scientific review groups§ 467f - Federal Food, Drug, and Cosmetic Act applications§ 679 - Application of Federal Food, Drug, and Cosmetic Act§ 821 - Rules and regulations§ 1034 - Inspection of egg products
Title 21 published on 10-May-2017 03:43The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR Part 14 after this date.2016-07-14; vol. 81 # 135 - Thursday, July 14, 201681 FR 45409 - Removal of Review and Reclassification Procedures for Biological Products Licensed Prior to July 1, 1972; Technical Amendment
2016-06-09; vol. 81 # 111 - Thursday, June 9, 201681 FR 37153 - Advisory Committee; Transmissible Spongiform Encephalopathies Advisory Committee; Termination
typeregulations.gov FR Doc.2016-13705 RIN Docket No.FDA-2016-N-0001 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective June 9, 2016. 21 CFR Part 14 SummaryThe Food and Drug Administration (FDA) is announcing the termination of the Transmissible Spongiform Encephalopathies Advisory Committee. This document removes the Transmissible Spongiform Encephalopathies Advisory Committee from the Agency&apos;s list of standing advisory committees.
2016-03-21; vol. 81 # 54 - Monday, March 21, 201681 FR 14975 - Patient Engagement Advisory Committee
typeregulations.gov FR Doc.2016-06240 RIN Docket No.FDA-2016-N-0001 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective March 21, 2016. 21 CFR Part 14 SummaryThe Food and Drug Administration (FDA) is amending the standing advisory committees&apos; regulations to add the Patient Engagement Advisory Committee.
2016-03-07; vol. 81 # 44 - Monday, March 7, 201681 FR 11663 - Pharmaceutical Science and Clinical Pharmacology Advisory Committee
typeregulations.gov FR Doc.2016-04940 RIN Docket No.FDA-2016-N-0001 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective March 7, 2016. The name change became applicable January 22, 2016. 21 CFR Part 14 SummaryThe Food and Drug Administration (FDA) is amending the standing advisory committees&apos; regulations to change the name of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. This action is being taken to reflect the change made to the charter for this advisory committee.
2015-04-06; vol. 80 # 65 - Monday, April 6, 201580 FR 18307 - Advisory Committee; Anti-Infective Drugs Advisory Committee
2015-03-20; vol. 80 # 54 - Friday, March 20, 201580 FR 14838 - Advisory Committee; Antiviral Drugs Advisory Committee; Termination
typeregulations.gov FR Doc.2015-06425 RIN Docket No.FDA-2012-N-0218 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective March 20, 2015. 21 CFR Part 14 SummaryThe Food and Drug Administration (FDA) is announcing the termination of the Antiviral Drugs Advisory Committee. This document removes the Antiviral Drugs Advisory Committee from the Agency&apos;s list of standing advisory committees.
2014-01-13; vol. 79 # 8 - Monday, January 13, 201479 FR 2093 - Advisory Committee; Pharmacy Compounding Advisory Committee
typeregulations.gov FR Doc.2014-00322 RIN Docket No.FDA-2013-N-1687 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective January 13, 2014. 21 CFR Part 14 SummaryThe Food and Drug Administration (FDA) is amending its regulations to update information regarding the Pharmacy Compounding Advisory Committee in FDA&apos;s Center for Drug Evaluation and Research in the Agency&apos;s list of standing advisory committees. This updated information regarding the Committee includes changes to its charter to reflect the recent enactment of the Drug Quality and Security Act.
2013-11-22; vol. 78 # 226 - Friday, November 22, 201378 FR 69991 - Advisory Committee; Veterinary Medicine Advisory Committee; Termination
typeregulations.gov FR Doc.2013-27854 RIN Docket No.FDA-2013-N-1380 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective November 22, 2013. 21 CFR Part 14 SummaryThe Food and Drug Administration (FDA) is announcing the termination of the Veterinary Medicine Advisory Committee. This document removes the Veterinary Advisory Committee from the Agency&apos;s list of standing advisory committees.
2013-03-20; vol. 78 # 54 - Wednesday, March 20, 201378 FR 17086 - Public Hearing Before a Public Advisory Committee; Technical Amendments